TickerFacts.

Foxo Technologies Inc. (FOXO): Operating Income

Annual figures by period end, from SEC filings.

-$10.33M
Year ended 2025-12-31
-$877.8K
Trailing 12 months to 2026-06-30
2021-12-31: -$15.03M2022-12-31: -$40.17M2023-12-31: -$22.19M2024-12-31: -$7.76M2025-12-31: -$10.33M-$10.33M
2021-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$10.33Mn/m2026-04-15, From 2025-01-01
2024-12-31-$7.76Mn/m2026-04-15, From 2024-01-01
2023-12-31-$22.19Mn/m2025-04-15, From 2023-01-01
2022-12-31-$40.17Mn/m2024-06-06, From 2022-01-01
2021-12-31-$15.03Mn/a2023-03-31, From 2021-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Foxo Technologies Inc. (FOXO)2025-12-31-$10.33Mn/m
OmniAb, Inc. (OABI)2025-12-31-$68.97Mn/m
MaxCyte, Inc. (MXCT)2025-12-31-$51.90Mn/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$10.57Mn/m
Absci Corp (ABSI)2025-12-31-$120.32Mn/m
NRC Health (NRC)2025-12-31$22.59M-35.8%
iSpecimen Inc. (ISPC)2025-12-31-$8.98Mn/m
OneMedNet Corp (ONMD)2025-12-31-$9.67Mn/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31-$421.4Kn/m

Compare FOXO, OABI, MXCT, BIAF side by side · Screen every company in Services-Commercial Physical & Biological Research ↗